AstraZeneca to Buy Stake in Acerta Pharma

AstraZeneca said it would buy a 55% stake in biotech company Acerta Pharma for $4 billion, in the U.K. drugmaker’s latest effort to rebuild its pipeline.

from WSJ.com: US Business http://ift.tt/1T36Nmq
via IFTTT